Caplin Point Laboratories Limited (BOM:524742)
India · Delayed Price · Currency is INR 2,176.05
+39.65 (1.86%)
At close: Sep 8, 2025
Caplin Point Laboratories Company Description
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India.
The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion.
It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags.
Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
Caplin Point Laboratories Limited
| Country | India |
| Founded | 1990 |
| Industry | Pharmaceutical Preparations |
| Employees | 3,406 |
| CEO | Sridhar Ganesan |
Contact Details
Address: Ashvich Tower Chennai, 600096 India | |
| Phone | 91 44 2496 8000 |
| Website | caplinpoint.net |
Stock Details
| Ticker Symbol | 524742 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sridhar Ganesan | Chief Executive Officer |
| D. Muralidharan | Chief Financial Officer |
| Partheeban Siddarth | Chief Operating Officer |